Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Carmen Belli"'
Autor:
Carmen Criscitiello, Giuseppe Curigliano, Stefania Morganti, Gloria Pellizzari, Paolo Tarantino, Carmen Belli, Edoardo Crimini, Matteo Repetto, Angela Esposito, Marzia Locatelli, Ida Minchella, Eleonora Nicolo’, Luca Boscolo Bielo, Grazia Castellano, Pier Paolo Maria Berton Giachetti, Gabriele Antonarelli, Liliana Ascione, Carmine Valenza, Beatrice Taurelli Salimbeni
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2f3c1f2945b4dd3bc96211b63e82c6a
Autor:
Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli, Giuseppe Curigliano
Publikováno v:
Cancers, Vol 16, Iss 2, p 281 (2024)
High microsatellite instability (MSI-H) derives from genomic hypermutability due to deficient mismatch repair function. Colorectal (CRC) and endometrial cancers (EC) are the tumor types that more often present MSI-H. Anti-PD(L)-1 antibodies have been
Externí odkaz:
https://doaj.org/article/20d13d9429cc4f14adc9c11c1d42e7ce
Autor:
Rachel Sanborn, Stephen Ansell, Vincent Ribrag, Diwakar Davar, Ecaterina Dumbrava, Elena Garralda, Carmen Belli, Clementine Sarkozy, Honey Kumar Oberoi, Amitkumar Mehta, Jasmine Zain, Alex Herrera, Andres Forero-Torres
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f49de7ab86b64fac820912c4384ac655
Autor:
Carmen Belli, Gabriele Antonarelli, Matteo Repetto, Luca Boscolo Bielo, Edoardo Crimini, Giuseppe Curigliano
Publikováno v:
Cancers, Vol 14, Iss 17, p 4278 (2022)
Cancers are composed of transformed cells, characterized by aberrant growth and invasiveness, in close relationship with non-transformed healthy cells and stromal tissue. The latter two comprise the so-called tumor microenvironment (TME), which plays
Externí odkaz:
https://doaj.org/article/9553b71427954f56a095b5e5309b9bf8
Autor:
Alessandra Raimondi, Vittorina Zagonel, Paolo Manca, Chiara Manai, Francesca Daniel, Salvatore Corallo, Michele Prisciandaro, Andrea Spallanzani, Virginia Quarà, Carmen Belli, Marta Vaiani, Maria Di Bartolomeo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Background Immune checkpoint inhibitors (ICIs) are the new standard of care in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC). Since tumor response dynamic parameters already shown a stron
Externí odkaz:
https://doaj.org/article/0c99b7dcadd04b1880b45908a67bc52d
Autor:
Pamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, Edoardo Crimini, Gabriele Antonarelli, Grazia Vivanet, Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender, Carmen Belli, Ida Minchella, Marzia Locatelli, Angela Esposito, Carmen Criscitiello, Giuseppe Curigliano
Publikováno v:
Cancers, Vol 13, Iss 22, p 5829 (2021)
Pivotal trials of COVID-19 vaccines did not include cancer patients, with questions remaining about their safety and efficacy in this population. Patients enrolled in early-phase clinical trials receive novel treatments with unknown efficacy and safe
Externí odkaz:
https://doaj.org/article/276687d39d9d44b594058b4f7472fd6a
Autor:
Matteo Repetto, Edoardo Crimini, Luca Boscolo Bielo, Elena Guerini-Rocco, Liliana Ascione, Andrea Bonfanti, Cristina Zanzottera, Luca Mazzarella, Alberto Ranghiero, Carmen Belli, Carmen Criscitiello, Angela Esposito, Massimo C.P. Barberis, Giuseppe Curigliano
Publikováno v:
European Journal of Cancer. 183:79-89
Autor:
Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano
Publikováno v:
Investigational New Drugs. 40:1133-1136
Purpose: TPX-0046 is designed to overcome resistance to FDA approved RET inhibitors Selpercatinib and Pralsetinib. Early prediction of resistance mechanisms to investigational drugs may facilitate subsequent drug and trial designs. This study aims to
Autor:
Lorenzo Piemonti, Massimo Falconi, Claudio Doglioni, Gaetano Di Terlizzi, Domenica Ceraulo, Vito Lampasona, Valeria Sordi, Paola Maggiora, Marina Scavini, Valentina Pasquale, Daniela Liberati, Roberto Nicoletti, Gianpaolo Balzano, Carmen Belli, Stefano Cereda, Erica Dugnani, Michele Reni
Purpose: We aimed to assess the safety and efficacy of metformin for treating patients with metastatic pancreatic cancer and to identify endocrine and metabolic phenotypic features or tumor molecular markers associated with sensitivity to metformin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1ed71f91ef5e3f7a023f38c5212766
https://doi.org/10.1158/1078-0432.c.6523601.v1
https://doi.org/10.1158/1078-0432.c.6523601.v1
Autor:
Carmen Belli, Matteo Repetto, Santosh Anand, Camillo Porta, Vivek Subbiah, Giuseppe Curigliano
Publikováno v:
British Journal of Cancer.